RxDoctor Payments Data

David Dine

Gerontology · Alliance, OHNPI 1396289534

Payments from drug & device makers

$864in general payments, 2019–2025

Across 45 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$374
  • Myovant Sciences Inc.$143
  • Axonics, Inc.$87
  • Clarus Therapeutics Inc.$61
  • Antares Pharma, Inc.$53
  • Blue Earth Diagnostics$25
  • plus $122 from 7 others

What the payments were for

  • Food & beverage$67678%
  • Education$18922%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$864 in reported general payments places this provider in the 70th percentile of 361 gerontology providers in Ohio.

See all gerontology providers in Ohio

Medicare billing

Part B allowed, 2024
$60,503
Medicare patients
432
Services billed
1,222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron95$61,197
GemtesaVibegron77$47,260
OrgovyxRelugolix12$31,982
Solifenacin Succinate299$16,179
Tamsulosin Hcl912$12,838
Tolterodine Tartrate ErTolterodine Tartrate92$7,097
Potassium Citrate ErPotassium Citrate52$6,689
Testosterone14$5,561
Methenamine Hippurate66$4,349
Oxybutynin Chloride431$4,184
Oxybutynin Chloride ErOxybutynin Chloride171$3,017
NitrofurantoinNitrofurantoin Macrocrystal74$2,277
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst55$1,982
Doxazosin Mesylate147$1,906
Testosterone Cypionate54$1,546

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$374$61,19795 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 361 gerontology providers in Ohio.

Other gerontology in Alliance

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →